Friedrich C. Prischl

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Parameters of prognostic relevance to the patency of vascular access in hemodialysis patients.

Friedrich C. Prischl, A Kirchgatterer, E Brandstätter et al. · Journal of the American Society of Nephrology · 1995 · 141 citations

Medicine, Nephrology, Surgery +16

Low-GDP fluid (Gambrosol trio(R)) attenuates decline of residual renal function in PD patients: a prospective randomized study

Marianne Haag–Weber, R Haake, M.S. Islam et al. · Nephrology Dialysis Transplantation · 2010 · 111 citations · Full text

Medicine, Biochemistry, Nephrology +17

Major determinants of hyperhomocysteinemia in peritoneal dialysis patients

Andreas Vychytil, Manuela Födinger, Gabriele Wölfl et al. · Kidney International · 1998 · 77 citations · Full text

Medicine, Biochemistry, Nephrology +12

Magnetic Resonance Imaging of the Peritoneal Cavity among Peritoneal Dialysis Patients, Using the Dialysate as “Contrast Medium”

Friedrich C. Prischl, T Muhr, Eva Seiringer et al. · Journal of the American Society of Nephrology · 2002 · 57 citations

Medicine, Radiology, Diagnostic Imaging +14